Regeneron Pharmaceuticals Inc. Share Price Today, Forecast Target, Chat & Where To Buy [REGN]

  • Today's Regeneron Pharmaceuticals Inc. share price is 761.85 (as of 16:00 02-Apr-2026) which is a change of -15.4 or -1.98% from the last closing price of 761.85.
  • With 1,000,524 shares traded this gives Regeneron Pharmaceuticals Inc. a market capitalisation of 80,542,627,048.
  • Regeneron Pharmaceuticals Inc.'s most recent daily high has been 770.11 and daily low 745. The Regeneron Pharmaceuticals Inc. share price 52 week high has been 821.11 and the 52 week low 476.49.
  • Based on the most recent Regeneron Pharmaceuticals Inc. share price opening of 761.85, the current Regeneron Pharmaceuticals Inc. EPS (earnings per share) are 41.89 and the PE (price earnings ratio) is 18.19.

Featured Brokers For Buying Regeneron Pharmaceuticals Inc. Shares

It currently costs 761.85 to buy one share in Regeneron Pharmaceuticals Inc. (as of 16:00 02-Apr-2026) which is a change of -15.4 or -1.98% from the last closing price of 777.25. To buy shares in Regeneron Pharmaceuticals Inc. you will need a stock trading platform like City Index.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Regeneron Pharmaceuticals Inc. A Good Investment?

The below Regeneron Pharmaceuticals Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.

Tell us what you think:

Scroll to Top